Global Infection Surveillance Solution Systems Market is growing at a steady CAGR of 4.5% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.
Access Full Report at https://databridgemarketresearch.com/reports/global-infection-surveillance-solutions-systems-market
The global infection surveillance solution systems market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to growing demand for the infection surveillance solution systems, booming across healthcare, technological advancements of global infection surveillance solution systems, introduction of novel automated systems. The market has witness developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative monitoring technology in infection surveillance solution systems. For instance, In June 2017, Wolters Kluwer showcases its Sentri7 advanced surveillance and clinical decision support solution in the annual conference of the Association for Professionals in Infection Control and Epidemiology (APIC). The product which offers approach for tracking, identifying and reporting infection prevention issues, streamlining workflows and promoting outcomes improvement. This type of action helps the company to increase their credibility.
Wolters Kluwer dominated the infection surveillance solution systems market. The other key players existing in the market includes BD, Cerner Corporation, Illumina, Inc., RL Solutions, GOJO Industries, Inc., S.C. Johnson & Son, Inc., Baxter, Vigilanz Corporation, IBM Corporation.
WOLTERS KLUWER:
Wolters Kluwer headquartered in South Holland, Netherlands was founded in 1836. The company focus on providing software solutions, services and professional information. The company is providing products in different products categories such as clinical decision support, clinical drug information, patient engagement, clinical terminologies, clinical surveillance, nursing education, nursing practice solutions, medical research, medical, nursing and allied health journal and book publishing solutions, continuing medical education. The market focused category lies under clinical surveillance. The company has five operating business categories such as health, tax & accounting, governance, risk & compliance, and legal & regulatory. The market focused category lies under health category. The company is continuously engaged in strategic relationship to enhance the product and service of the infection surveillance solution systems such as,
- In February 2017, Wolters Kluwer announced that its Sentri7 solution has received the best Category Leader award for Clinical Decision Support Surveillance in the KLAS Software & Services report. After receiving the best award, the company increases its credibility and also increases the image of their product portfolio in the market.
It has its global networks through direct sales representatives and distributors in the Global. The company has various subsidiaries such as CCH (U.S.), LWW; Lippincott Williams & Wilkins (U.S.), Enable North America Corp. (U.S.), CT Corporation (U.S.), CT Lien Solutions (U.S.) and others.
BD
BD is headquartered in New Jersey, U.S., founded in 1897. The company focuses on the development, manufacturing and sales of medical supplies, devices, laboratory equipment and diagnostic products. BD offers various products such as anesthesia delivery, biosciences, bio surgery, cervical cancer screening, diabetes care, drug delivery systems, gastrointestinal care, hazardous drug safety, hernia repair and fixation, home care, infection prevention, infusion therapy, interventional specialties, lab automation, medication and supply management, microbiology solutions, molecular diagnostics, patient monitoring and temperature management, prostate health, respiratory care, sharps disposal solutions, single cell multiomics, software solutions, specimen collection, surgical instruments, syringes and needles, urology and kidney health, vascular access, vascular surgery, wound care. The market focused products category lies under software solutions. The company operates through three business segments which include Medical, Life Sciences, and Interventional. The market focused category lies under Life Sciences. The company is continuously engaged in strategic relationship to enhance the product and services of the infection surveillance solution systems such as
- In September 2017, Becton, Dickinson and Company announced strategic partnership with the Canadian Society for Medical Laboratory Science (CSMLS) for education of best practice and current clinical standards for Canadian Medical Laboratory Technologists (MLTs) and Medical Laboratory Assistants (MLAs). By this collaboration company will enhance its product portfolio in the market as the collaboration has a strong focus on improving patient’s care.
The company has wide geographic presence in North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific. It operates through its subsidiaries such as CareFusion Corporation (U.S.), C. R. Bard, Inc. (U.S), Accuri Cytometers Inc. (U.S.), TVA Medical, Inc. (U.S.), Becton Dickinson Acute Care Inc. (West Africa), TriPath Imaging, Inc. (U.S.) and many others.
ILLUMINA, INC.
Illumina, Inc headquartered in California, U.S. was incorporated in 1998. The company focus to apply innovative technologies for the analysis of genetic variation and function. Illumina, Inc. offers various innovative solutions for better Life such as Clinical, Research & Applied Markets. The market focused category lies under Clinical.
The company has global presence in South America, Europe, Asia- Pacific, North America, Middle East and Africa. The company has subsidiaries such as Edico Genome (U.S.), Advanced Liquid Logic, Inc. (U.S.), BlueGnome Ltd (U.K.), Nextbio (U.S.), Illumina Cambridge Ltd (U.S.) and others.
